WordNet

the act of keeping something within specified bounds (by force if necessary); "the restriction of the infection to a focal area" (同)confinement
a principle that limits the extent of something; "I am willing to accept certain restrictions on my movements" (同)limitation
any of several complex proteins that are produced by cells and act as catalysts in specific biochemical reactions

PrepTutorEJDIC

(…を)『制限』(『限定』)『すること』《+『of』+『名』》,制限(限定)されていること / 〈C〉(…に対する)制限事項,制約《+『on』(『against』)+『名』》
酵素

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人の非糖尿病性慢性腎臓病患者に対する降圧療法と病状の進展 antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults
2. 小児におけるネフローゼ症候群の対症療法 symptomatic management of nephrotic syndrome in children
3. 急性非代償性心不全の治療：治療の要素 treatment of acute decompensated heart failure components of therapy
4. 塩分摂取量および塩分摂取量制限と原発性（本態性）高血圧 salt intake salt restriction and primary essential hypertension
5. 蛋白質摂取制限と慢性腎臓病の進行 protein restriction and progression of chronic kidney disease

Characteristics of Yersinia enterocolitica biotype 1A strains isolated from patients and asymptomatic carriers.

Stephan R, Joutsen S, Hofer E, Säde E, Björkroth J, Ziegler D, Fredriksson-Ahomaa M.SourceInstitute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.Eur J Clin Microbiol Infect Dis.2013 Jan 26. [Epub ahead of print]
Yersinia enterocolitica biotype 1A strains are frequently isolated from the environment, foods, and animals, and also from humans with yersiniosis. There are controversial reports on the pathogenicity of biotype 1A strains. In this study, 811 fecal samples from asymptomatic humans from Switzerland w
PMID 23354676
PMID 22271301
PMID 22213117

Inhibition of Restriction Enzymes EcoRI, BamHI and HindIII by Phenethylphenylphthalimides Derived from Thalidomide

Motoshima Kazunori,Ishikawa Minoru,Hashimoto Yuichi,Sugita Kazuyuki
Chemical and Pharmaceutical Bulletin 59(7), 2011
… We discovered inhibitors of the restriction enzymes EcoRI, BamHI and HindIII by screening our library of compounds with a phenethylphenylphthalimide skeleton, based on α-glucosidase inhibitors and liver X receptor antagonists derived from thalidomide. … Structural development afforded the potent restriction enzyme inhibitors 25 and 26. …
NAID 130000748024

吉田隆延,川部眞登,宮田雄一郎,門田育生,有江力
日本植物病理學會報 69(1), 30, 2003-02-25
… Restriction enzyme-mediated integration (REMI)法により,キャベツ萎黄病菌Fusarium oxysporum f.sp.conglutinansの病原性変異株REMI10が得られた.このREMI10について解析した結果,形質転換ベクターが,他の植物病原糸状菌のアスパラギン酸プロテイナーゼと相同性の高い遺伝子faplのHindIII部位に1コピー挿入されていることが明らかになった.また,reverse transcription (RT)-PCRを利用して,培地及びキャベツ萎黄病菌 …
NAID 110002716646

HARANO Keiko,Tin Yi Yi,HARANO Teruo
Kawasaki medical journal 29(1/2), 9-16, 2003
… The haplotype of the β-globin-like gene cluster was determined by the presence (+) or absence (-) of the restriction enzyme site in the PCR product including the polymorphic site. … Polymorphism or the haplotype were determined at seven sites, 5' to the ε-gene/HincII, in the ^Gγ-gene/HindIII, in the ^Aγ-gene/HindIII, in the ψβ-gene/HincII, 3' to the ψβ-gene/HincII, in the β-IVS II/AvaII and 3' to the β-gene/BamHI, in the β-globin-like gene cluster. …
NAID 110000008739